We look forward to working with your office with the goal of limiting the effect on your daily operations
When Selectivity Matters Most: The selective action of AOD-9604 is particularly valuable for individuals with insulin resistance, pre-diabetes, or type 2 diabetes who cannot tolerate glucose elevation, those with personal or family history of cancer who wish to avoid IGF-1 elevation, people seeking pure fat loss without muscle gain or other body composition changes, athletes who need fat loss without anabolic effects or hormonal changes that might affect testing, individuals on complex medication regimens where growth hormones effects would require dose adjustments, and those who prefer targeted interventions over systemic hormonal therapy
Obesity pathophysiology and metabolic science: Understanding the hormonal, neurological, and genetic factors that drive weight gain and resist weight loss GLP-1 receptor agonist mastery: Comprehensive training on semaglutide, tirzepatide, and emerging agents, including prescribing protocols, titration schedules, contraindication screening, and side effect management Comprehensive pharmacotherapy: Phentermine, phentermine-topiramate, naltrexone-bupropion, orlistat, metformin, and combination strategies Peptide therapy and compounded medications: Navigating the regulatory and clinical landscape for compounded semaglutide and adjunctive peptides Metabolic testing and body composition analysis: Hands-on training with indirect calorimetry, DEXA scanning, and bioimpedance analysis Nutritional programming: Developing individualized meal plans, protein optimization for lean mass preservation, and supplement protocols Behavioral health integration: Practical CBT and motivational interviewing techniques for the clinical weight management setting Business and practice operations: Program pricing, patient acquisition, billing and coding, staff training, and scaling strategies Why AAOPM The AAOPM approach to medical weight loss certification is distinguished by its emphasis on immediate clinical applicability
Tier four includes vendors with no testing data, negative community feedback, or obvious quality concerns
What happens when competition in healthcare disappears
